295 related articles for article (PubMed ID: 25188319)
1. The AMPK agonist AICAR inhibits TGF-β1 induced activation of kidney myofibroblasts.
Chen KH; Hsu HH; Lee CC; Yen TH; Ko YC; Yang CW; Hung CC
PLoS One; 2014; 9(9):e106554. PubMed ID: 25188319
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of spleen tyrosine kinase (syk) suppresses renal fibrosis through anti-inflammatory effects and down regulation of the MAPK-p38 pathway.
Chen KH; Hsu HH; Yang HY; Tian YC; Ko YC; Yang CW; Hung CC
Int J Biochem Cell Biol; 2016 May; 74():135-44. PubMed ID: 26948651
[TBL] [Abstract][Full Text] [Related]
3. Activation of AMP-activated protein kinase prevents TGF-β1-induced epithelial-mesenchymal transition and myofibroblast activation.
Thakur S; Viswanadhapalli S; Kopp JB; Shi Q; Barnes JL; Block K; Gorin Y; Abboud HE
Am J Pathol; 2015 Aug; 185(8):2168-80. PubMed ID: 26071397
[TBL] [Abstract][Full Text] [Related]
4. AMPK Activation by 5-Amino-4-Imidazole Carboxamide Riboside-1-β-D-Ribofuranoside Attenuates Alkali Injury-Induced Corneal Fibrosis.
Nuwormegbe SA; Kim SW
Invest Ophthalmol Vis Sci; 2020 Jun; 61(6):43. PubMed ID: 32561924
[TBL] [Abstract][Full Text] [Related]
5. Noscapine alleviates unilateral ureteral obstruction-induced inflammation and fibrosis by regulating the TGFβ1/Smads signaling pathways.
Hung CC; Chen KH; Hsu HH; Chang MY; Ko YC; Yang HY; Yang CW
Biochim Biophys Acta Mol Cell Res; 2024 Jan; 1871(1):119594. PubMed ID: 37730129
[TBL] [Abstract][Full Text] [Related]
6. AICAR-dependent AMPK activation improves scar formation in the aged heart in a murine model of reperfused myocardial infarction.
Cieslik KA; Taffet GE; Crawford JR; Trial J; Mejia Osuna P; Entman ML
J Mol Cell Cardiol; 2013 Oct; 63():26-36. PubMed ID: 23871790
[TBL] [Abstract][Full Text] [Related]
7. Melatonin ameliorates renal fibroblast-myofibroblast transdifferentiation and renal fibrosis through miR-21-5p regulation.
Li N; Wang Z; Gao F; Lei Y; Li Z
J Cell Mol Med; 2020 May; 24(10):5615-5628. PubMed ID: 32243691
[TBL] [Abstract][Full Text] [Related]
8. WISP3 prevents fibroblast-myofibroblast transdifferentiation in NRK-49F cells.
Yi Y; Ma J; Jianrao L; Wang H; Zhao Y
Biomed Pharmacother; 2018 Mar; 99():306-312. PubMed ID: 29353205
[TBL] [Abstract][Full Text] [Related]
9. Alpha1-Antitrypsin Attenuates Renal Fibrosis by Inhibiting TGF-β1-Induced Epithelial Mesenchymal Transition.
Cho JH; Ryu HM; Oh EJ; Yook JM; Ahn JS; Jung HY; Choi JY; Park SH; Kim YL; Kwak IS; Kim CD
PLoS One; 2016; 11(9):e0162186. PubMed ID: 27607429
[TBL] [Abstract][Full Text] [Related]
10. Hepatocyte growth factor suppresses renal interstitial myofibroblast activation and intercepts Smad signal transduction.
Yang J; Dai C; Liu Y
Am J Pathol; 2003 Aug; 163(2):621-32. PubMed ID: 12875981
[TBL] [Abstract][Full Text] [Related]
11. [Tofacitinib inhibits the transformation of lung fibroblasts into myofibroblasts through JAK/STAT3 pathway].
He S; Chen X; Cheng Q; Zhu L; Zhang P; Tong S; Xue J; DU Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2024 Jun; 56(3):505-511. PubMed ID: 38864137
[TBL] [Abstract][Full Text] [Related]
12. HL156A, a novel pharmacological agent with potent adenosine-monophosphate-activated protein kinase (AMPK) activator activity ameliorates renal fibrosis in a rat unilateral ureteral obstruction model.
Tsogbadrakh B; Ju KD; Lee J; Han M; Koh J; Yu Y; Lee H; Yu KS; Oh YK; Kim HJ; Ahn C; Oh KH
PLoS One; 2018; 13(8):e0201692. PubMed ID: 30161162
[TBL] [Abstract][Full Text] [Related]
13. Lefty-1 alleviates TGF-β1-induced fibroblast-myofibroblast transdifferentiation in NRK-49F cells.
Zhang L; Zhang J; Xu C; Zhou X; Wang W; Zheng R; Hu W; Wu P
Drug Des Devel Ther; 2015; 9():4669-78. PubMed ID: 26316705
[TBL] [Abstract][Full Text] [Related]
14. Astragaloside IV inhibits renal tubulointerstitial fibrosis by blocking TGF-β/Smad signaling pathway in vivo and in vitro.
Wang L; Chi YF; Yuan ZT; Zhou WC; Yin PH; Zhang XM; Peng W; Cai H
Exp Biol Med (Maywood); 2014 Oct; 239(10):1310-24. PubMed ID: 24879422
[TBL] [Abstract][Full Text] [Related]
15. AMPK agonist AICAR ameliorates portal hypertension and liver cirrhosis via NO pathway in the BDL rat model.
Hu L; Su L; Dong Z; Wu Y; Lv Y; George J; Wang J
J Mol Med (Berl); 2019 Mar; 97(3):423-434. PubMed ID: 30721324
[TBL] [Abstract][Full Text] [Related]
16. CTRP3 attenuates post-infarct cardiac fibrosis by targeting Smad3 activation and inhibiting myofibroblast differentiation.
Wu D; Lei H; Wang JY; Zhang CL; Feng H; Fu FY; Li L; Wu LL
J Mol Med (Berl); 2015 Dec; 93(12):1311-25. PubMed ID: 26138247
[TBL] [Abstract][Full Text] [Related]
17. Reversal of TGF-β1 stimulation of α-smooth muscle actin and extracellular matrix components by cyclic AMP in Dupuytren's-derived fibroblasts.
Satish L; Gallo PH; Baratz ME; Johnson S; Kathju S
BMC Musculoskelet Disord; 2011 May; 12():113. PubMed ID: 21612641
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of TRPC6 suppressed TGFβ-induced fibroblast-myofibroblast transdifferentiation in renal interstitial NRK-49F cells.
Jiang S; Gu L; Hu Y; Ren Y; Yang Z; Chai C; Yu B; Ge H; Cao Z; Zhao F
Exp Cell Res; 2022 Dec; 421(1):113374. PubMed ID: 36206825
[TBL] [Abstract][Full Text] [Related]
19. Hepatocyte growth factor inhibits TGF-β1-induced myofibroblast differentiation in tendon fibroblasts: role of AMPK signaling pathway.
Cui Q; Fu S; Li Z
J Physiol Sci; 2013 May; 63(3):163-70. PubMed ID: 23371911
[TBL] [Abstract][Full Text] [Related]
20. Blocking the class I histone deacetylase ameliorates renal fibrosis and inhibits renal fibroblast activation via modulating TGF-beta and EGFR signaling.
Liu N; He S; Ma L; Ponnusamy M; Tang J; Tolbert E; Bayliss G; Zhao TC; Yan H; Zhuang S
PLoS One; 2013; 8(1):e54001. PubMed ID: 23342059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
